Keep pulling the thread on Alec Kimmelman.
The funding level for a standard R01 research grant from the National Institutes of Health has not changed in approximately 30 years, failing to keep up with inflation.
Approximately 70% of patients at NYU Langone are insured through government programs such as Medicare and Medicaid.
NYU Langone would be forced to shut down if it lost its ability to accept Medicare and Medicaid insurance.
NYU Langone has deployed an AI "co-pilot" in its emergency departments to analyze patient data in real-time and alert physicians to the probability of life-threatening diagnoses before discharge.
NYU Langone is a health system with $15 billion in annual revenue.
The NYU Langone health system includes almost 400 ambulatory sites and seven inpatient sites.
Over an 18-year period, former CEO Bob Grossman grew NYU Langone from a $2 billion regional hospital into a premier national health system.
NYU Langone has maintained a single, unified electronic medical record system across all its sites for more than a decade.
At NYU Langone's Center for Molecular Oncology, every cancer patient receives a liquid biopsy.
NYU Langone is conducting a demonstration project to prove that scaled liquid biopsy programs are efficacious enough to compel reimbursement from insurance companies.
The five-year survival rate for pancreatic cancer has increased from approximately 5% to between 15% and 16% over the past few decades.
A proposed 40-50% cut to the National Institutes of Health budget created significant uncertainty that led some research institutions to stop hiring.